Accueil › Cancer du sein › Californie › Mountain View
Essais cliniques pour Cancer du sein à Mountain View, CA
26 études pour Cancer du sein recherchent des participants dans et autour de Mountain View (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Recrutement en coursPhase 3
- Stanford Women's Cancer Center, Palo Alto · à 5 mi
A Study of PHST001 in Advanced Solid Tumors
Recrutement en coursPhase 1
- Stanford University School of Medicine, Palo Alto · à 5 mi
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Recrutement en coursPhase 3
- El Camino Hospital, Mountain View
- Palo Alto Medical Foundation, Mountain View
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
Recrutement en coursPhase 1/2
- Stanford Medicine Cancer Center, Stanford · à 5 mi
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Recrutement en coursPhase 3
- El Camino Hospital Cancer Center ( Site 0096), Mountain View
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Recrutement en coursPhase 1
- Stanford University Medical Center, Stanford · à 5 mi
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Recrutement en coursPhase 1
- Stanford University Medical Center, Stanford · à 5 mi
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Recrutement en coursPhase 3
- Stanford Cancer Center, Palo Alto · à 5 mi
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Recrutement en coursPhase 3
- Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center, Palo Alto · à 5 mi
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Recrutement en coursPhase 3
- Stanford Women's Cancer Center, Palo Alto · à 5 mi
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
Recrutement en coursPhase 1
- Stanford University Hospital, Stanford · à 5 mi
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Recrutement en coursPhase 3
- Research Site, Palo Alto · à 5 mi
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
Recrutement en coursPhase 2
- Stanford Cancer Institute, Palo Alto · à 5 mi
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Recrutement en coursPhase 3
- Palo Alto Medical Foundation Research Center, Palo Alto · à 5 mi
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Recrutement en coursPhase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · à 5 mi
- et 1 autres
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
Recrutement en coursPhase 2
- Stanford University, Stanford · à 5 mi
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Recrutement en coursPhase 2/3
- Local Institution - 0358, Stanford · à 5 mi
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Recrutement en coursPhase 3
- Stanford Medicine Cancer Center - Stanford Women's Cancer Center, Palo Alto · à 5 mi
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Recrutement en coursPhase 1
- Stanford University Medical Center, Palo Alto · à 5 mi
Magnetic Resonance Imaging of Breast Cancer
Recrutement en coursVolontaires sains bienvenus
- Stanford University School of Medicine, Stanford · à 5 mi
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Recrutement en coursÉtude observationnelle
- Stanford University School of Medicine, Stanford · à 5 mi
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Recrutement en coursPhase 3
- Palo Alto Medical Foundation-Camino Division, Mountain View
- Palo Alto Medical Foundation Health Care, Palo Alto · à 5 mi
- Stanford Cancer Institute Palo Alto, Palo Alto · à 5 mi
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Recrutement en coursPhase 1
- Stanford Cancer Institute, Stanford · à 5 mi
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma
Recrutement en cours
- Stanford University, Stanford · à 5 mi
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Recrutement en coursÉtude observationnelle
- Stanford Cancer Institute, Palo Alto · à 5 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Stanford · à 5 mi
Essais pour Cancer du sein dans d'autres villes
- New York City, NY136 études
- Houston, TX126 études
- Boston, MA112 études
- Nashville, TN81 études
- Los Angeles, CA73 études
- Edison, NJ68 études
- St. Louis, MO64 études
- Queens, NY64 études
- Durham, NC64 études
- Chicago, IL59 études
- Philadelphia, PA56 études
- Dallas, TX55 études
Autres études à Mountain View
- Cancer (tous types)40 études
- Cancer métastatique25 études
- Cancer du poumon non à petites cellules21 études
- Leucémie aiguë myéloïde19 études
- Cancer de l'ovaire19 études
- Trouble du spectre de l'autisme17 études
- Cancer du poumon17 études
- Cancer de la prostate15 études
- Insuffisance cardiaque15 études
- Autisme13 études
- Leucémie aiguë lymphoblastique13 études
- Cancer colorectal13 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.